Clinical trial
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses…
NCT00134199 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134199 |
|---|---|
| Title | A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects |
| Official title | A 6-Month, Randomized, Double-Blind, Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945,598 On Weight Loss In Obese Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | CP-945, 598, sibutramine |
| Enrollment | 282 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Aug 24, 2005 |
| Last update posted | Aug 12, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: